Cargando…

Long term prophylactic anticoagulation for portal vein thrombosis after splenectomy: A systematic review and meta-analysis

AIM: The aim of this study was to evaluate the efficacy and safety of the anticoagulants for the prevention of portal vein system thrombosis (PVST) in patients with cirrhosis after splenectomy and explore the optimal time of anticoagulant administration. METHODS: A systematic literature search was p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liao, Zheng, Wang, Zixiang, Su, Chenguang, Pei, Yinxuan, Li, Weiwei, Liu, Jinlong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10426921/ https://www.ncbi.nlm.nih.gov/pubmed/37582105 http://dx.doi.org/10.1371/journal.pone.0290164

Ejemplares similares

The effect of neutrophil extracellular traps in venous thrombosis
por: Li, Weiwei, et al.
Publicado: (2023)

Portal Vein Thrombosis After Laparoscopic Splenectomy: An Ongoing Clinical Challenge
por: Miniati, Douglas N., et al.
Publicado: (2005)

Splenic and Portal Vein Thrombosis after Splenectomy: A Case Report
por: Saliba, Thomas, et al.
Publicado: (2022)

Low‐molecular weight heparin prevents portal vein system thrombosis after splenectomy: a systematic review and meta‐analysis
por: Yang, Ming, et al.
Publicado: (2020)

Severe Portal Vein Thrombosis During Eltrombopag Treatment Concomitant Splenectomy for Immune Thrombocytopenia
por: Saito, Makoto, et al.
Publicado: (2021)

Research on Portal Venous Hemodynamics and Influencing Factors of Portal Vein System Thrombosis for Wilson’s Disease after Splenectomy
por: Zheng, Zhou, et al.
Publicado: (2022)

Successful conversion therapy for unresectable hepatocellular carcinoma is getting closer: A systematic review and meta-analysis
por: Pei, Yinxuan, et al.
Publicado: (2022)

Efficacy of transarterial chemoembolization monotherapy or combination conversion therapy in unresectable hepatocellular carcinoma: A systematic review and meta-analysis
por: Li, Weiwei, et al.
Publicado: (2022)

Investigation of Thrombosis Volume, Anticoagulants, and Recurrence Factors in Portal Vein Thrombosis with Cirrhosis
por: Suda, Tsuyoshi, et al.
Publicado: (2020)

Update on Management of Portal Vein Thrombosis and the Role of Novel Anticoagulants
por: Wu, Matthew, et al.
Publicado: (2019)

Timing of anticoagulation for the management of portal vein thrombosis in liver cirrhosis
por: Valeriani, Emanuele, et al.
Publicado: (2023)

Hemorheological Alteration in Patients with Cirrhosis Clinically Diagnosed with Portal Vein System Thrombosis After Splenectomy
por: Huang, Long, et al.
Publicado: (2021)

Early Initiation of Anticoagulation Improves the Long-Term Prognosis in Patients With Antiphospholipid Syndrome Associated Portal Vein Thrombosis
por: You, Hanxiao, et al.
Publicado: (2021)

Preventive use of low molecular weight heparin in portal vein system thrombosis after splenectomy without portal hypertension
por: Wei, Qiang, et al.
Publicado: (2022)

Machine learning predicts portal vein thrombosis after splenectomy in patients with portal hypertension: Comparative analysis of three practical models
por: Li, Jian, et al.
Publicado: (2022)

Resveratrol Reduces the Incidence of Portal Vein System Thrombosis after Splenectomy in a Rat Fibrosis Model
por: Xu, Meng, et al.
Publicado: (2016)

Nomogram-based prediction of portal vein system thrombosis formation after splenectomy in patients with hepatolenticular degeneration
por: Zheng, Zhou, et al.
Publicado: (2023)

Clinical value of AKR1B10 in hepatocellular carcinoma: A systematic review and meta-analysis
por: Wang, Zixiang, et al.
Publicado: (2022)

Long-term efficacy and safety of anticoagulant for cavernous transformation of the portal vein cirrhotic patient with extrahepatic portal vein obstruction
por: Zhou, Yongjie, et al.
Publicado: (2023)

P-Selectin Level at First and Third Day After Portal Hypertensive Splenectomy for Early Prediction of Portal Vein Thrombosis in Patients With Cirrhosis
por: Wei, Yunhai, et al.
Publicado: (2018)

Incidence of portal vein thrombosis after splenectomy and its influence on transjugular intrahepatic portosystemic shunt stent patency
por: Dong, Fang, et al.
Publicado: (2019)

Early prevention and risk factors analysis of portal vein system thrombosis after laparoscopic splenectomy and pericardial devascularization
por: Li, Yongning, et al.
Publicado: (2022)

Portal Vein Thrombosis
por: Cohen, Ronny, et al.
Publicado: (2015)

Management of Anticoagulation for Portal Vein Thrombosis in Individuals with Cirrhosis: A Systematic Review
por: Huard, Geneviève, et al.
Publicado: (2012)

Anticoagulation in non-malignant portal vein thrombosis is safe and improves hepatic function
por: Scheiner, Bernhard, et al.
Publicado: (2018)

Anticoagulant therapy in patients with liver cirrhosis and portal vein thrombosis: insights for the clinician
por: Basili, Stefania, et al.
Publicado: (2018)

Danaparoid sodium-based anticoagulation therapy for portal vein thrombosis in cirrhosis patients
por: Hayashi, Takehiro, et al.
Publicado: (2019)

Treatment of direct oral anticoagulants in patients with liver cirrhosis and portal vein thrombosis
por: Chun, Ho Soo, et al.
Publicado: (2021)

A novel method detecting the key clinic factors of portal vein system thrombosis of splenectomy & cardia devascularization patients for cirrhosis & portal hypertension
por: Wang, Mingzhao, et al.
Publicado: (2019)

Pharmacologic Prophylaxis of Portal Venous System Thrombosis after Splenectomy: A Meta-Analysis
por: Qi, Xingshun, et al.
Publicado: (2014)

Newer Oral Anticoagulants in the Treatment of Acute Portal Vein Thrombosis in Patients with and without Cirrhosis
por: Priyanka, P., et al.
Publicado: (2018)

Direct oral anticoagulant administration in cirrhotic patients with portal vein thrombosis: What is the evidence?
por: Biolato, Marco, et al.
Publicado: (2022)

Melioidosis with Portal Vein Thrombosis
por: Direksunthorn, Thanyaporn
Publicado: (2017)

The Efficacy and Safety of Anticoagulants in the Treatment of Cirrhotic Portal Vein Thrombosis: A Systematic Review and Meta-Analysis
por: Zhang, Zhiqi, et al.
Publicado: (2022)

Serum Lipoprotein (a) on Postoperative Day 3: A Strong Predictor of Portal and/or Splenic Vein Thrombosis in Cirrhotic Patients With Splenectomy
por: Shi, Zhiyong, et al.
Publicado: (2020)

Emergency Splenectomy in a Patient with Splenic Marginal Zone Lymphoma, Acute Portal Vein Thrombosis, and Chronic Viral Hepatitis B
por: Karpova, Radmila, et al.
Publicado: (2021)

Splenic volume and splenic vein diameter are independent pre-operative risk factors of portal vein thrombosis after splenectomy: a retrospective cohort study
por: Péré, Guillaume, et al.
Publicado: (2021)

Long-term efficacy of subtotal splenectomy due to portal hypertension in cirrhotic patients
por: Chu, Haibo, et al.
Publicado: (2015)

Prediction of the Factors Influencing the Shengjing Classification of Portal Vein Thrombosis after Splenectomy for Portal Hypertension in Cirrhosis: A Single-Center Retrospective Case-Control Study
por: Song, Zimin, et al.
Publicado: (2020)

A Case of Portal Vein Thrombosis by Protein C and S Deficiency Completely Recanalized by Anticoagulation Therapy
por: Choi, Bo Kyoung, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_mcgh18nbqg0r45h5bm7ueulbh1